Risk factors for failure of Helicobacter pylori therapy — results of an individual data analysis of 2751 patients
- 19 December 2002
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 17 (1), 99-109
- https://doi.org/10.1046/j.1365-2036.2003.01396.x
Abstract
Aim : To study risk factors for failure of Helicobacter pylori eradication treatment. Methods : Individual data from 2751 patients included in 11 multicentre clinical trials carried out in France and...Keywords
This publication has 27 references indexed in Scilit:
- cagA Status and Eradication Treatment Outcome of Anti- Helicobacter pylori Triple Therapies in Patients with Nonulcer DyspepsiaJournal of Clinical Microbiology, 2001
- How to Treat Heliobacter pyloriGastroenterology Clinics of North America, 2000
- Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatmentGut, 2000
- Absence of Benefit of EradicatingHelicobacter pyloriin Patients with Nonulcer DyspepsiaNew England Journal of Medicine, 1999
- A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication ratesAlimentary Pharmacology & Therapeutics, 1999
- One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH studyAlimentary Pharmacology & Therapeutics, 1999
- One week triple therapy for Helicobacter pylori: a multicentre comparative studyGut, 1997
- Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.Gut, 1997
- Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatmentAlimentary Pharmacology & Therapeutics, 1996
- The Sydney System: Histological divisionJournal of Gastroenterology and Hepatology, 1991